Could Be More Shorting Before Extent Of Losses Goes Public.
To Bad The Three Posters With 17 Identities Can't Find The Time To Post About The Failings Of The Senile One. AKA; "Dementia Raj'. It Is Always About The Future Of SPPI, Never The Present. Meanwhile Raj And The Board Are Drawing Salary And Bonus! A True CASI Clone!
Filing A Plan, And Then Filing The Additional Plans And The Applications For All Of The New Drugs Seems To Be Big Problem For SPPI. Look At The Progress Of The Three Drugs That Raj Was So Excited About Selling In China! The Patents May Expire Or The Drugs Will Face Bio-similar Or Generic Competition Before Any SPPI Drugs Are Sold.
More Shares With Even More Dilution After Quarter Ended, Lost Money (-14 ), 18,Million Less In Assets, 6 Drugs On The Market And Less Total Dollars Of Sales, Less Total Stockholders Equity, Greater Accumulated Deficit,Marqibo Sales Off 50% Fusilev Sales Off 25%, Zevalin Sales Off 34%, Stock Based Compensation Up 29.4%, Restricted Stock Awards Up By 1,000,000 Shares, AND "CASI will be responsible for the development and commercialization of these three drugs, including the submission of import drug registration applications to regulatory authorities and conducting any confirmatory clinical studies in greater China. We will provide CASI with future commercial supply of the CASI Out-Licensed Products under typical market terms".
The Management Team Of Raj And Friends Is All About Themselves. They Have No Desire To SELL SPPI Drugs In Excess Of The Minimum Amount Required To Keep The Company In Operation. CASE IN POINT: CASI. The Partnering With The Drug-less Drug Company Was Just Another Way To Buy Time For Management To Extract Wealth From The Shareholders. Why Partner With A Company That Has Never Sold A Drug, Much Less Developed One? The Answer Is To Prevent Any Sales Of SPPI Drugs In The Largest Market In The Word While The "TEAM" Takes Salary And Bonuses From The Company. Look Out For More "Promising" Investments That Produce No Profitable Revenue For Shareholders. CASI Has Done Exactly The Same Thing For It's ENTIRE 22 Year Existence. Not One Drug Through A Phase 3 Trial. Not One Drug On The Market.. CASI LOST A HALF A BILLION DOLLARS, While Drawing Paychecks.
AND Then Raj Had To Raise Another ~23 Million Dollars On The 26 Of April? Just How Much More Dilution Will Be Required To Fund You "Dilutions" Of Grandeur Raj?
The Worst Management Combination In Biotech! The Pre Recorded Presentation By Raj On The Conference Call Did Not Fool Me. To Me It Was Further Proof That This Senile Old Dementia Patient, That Previously Stuttered And Stammered And Lost His Place, Needs To Go Away Before He Allows The Short Funds To Take The Stock Below One Dollar. Collectively You Have Management By, Of And For The Short Hedge Funds. He Partnered With The 1/2 BILLION Dollar Losing, Drugless, Stoner, ADHD CASI, A Company That Can't Even Fill Out The APPLICATION For SPPI Drugs Sales In Mainland China. The Two Drugs That Could Be Sold In Hong Kong Because Of The Free Trade Agreement Have No Registration Paperwork Filed After 1 1/2 years. The Partnership With CASI To Gain Approval For Spectrum Drugs In China Is Reason Enough For The Board And Raj To Be Fired Today.
11 In A Row! NO! Are You Interpreting My Replies From The Airport As Proof That SPPI Is A Company To Invest In At $7.50 Per Share? Nice Try, Most New Investors At This Time Can Count And Do The Math On Spectrum's 10Q. They Will Understand That Raj's Bernard Madoff Investment Plan Can Only Bring Them A Tax Loss Over The Next 18 Months. I Believe Potential Investors Should Wait Until Raj And The Yes Men Board Are Gone. What Do I Know Though, Other Than The Meaning Of 6 Verses 11.
They Are A Company That Has Never Sold, Developed A Drug That Got Approved Or Even Into A Phase 3 Trial. "STONERS" That Lost HALF A BILLION DOLLARS FOR NOTHING!
It Would Seem To Me That As A Long ,You Should Be Congratulating Me On Taking The Wrong Side Of The SPPI Short Pump And Dump. If I Was Short And Forced To Cover You Could Possibly Sell Me The Shares I Needed At An Inflated Price!
After 22 YEARS, CASI Gets Approval To Conduct A PHASE TWO Clinical Trial In CHINA. Please Think Carefully About This News Item! In Twenty-Two YEARS And Having Spent ONE HALF BILLION DOLLARS, They Are "Possibly" Going To Start A Phase TWO Trial For A Compound In A Crowded Market. How Can Anyone Not Want To Invest In Both CASI And SPPI, Their 20% Shareholder. It Is Beyond Belief That ANYONE OTHER THAN A SHORT Would Invest Any Money Here EXCEPT TO SHORT!
As Per 10Q!
The Last Sentence Corrected: "Being Paid To The Facilitators"
It Took CASI 14 MONTHS To File The Initial Application Paperwork Required For Just One Drug Before The Actual Application Paperwork Can Be Filed. CASI Has Not Filed Initial Application Paperwork For The Other 2 Drugs. That Is What Happens When You Partner With A Company That Has Lost ONE HALF BILLION DOLLARS And Has Never Developed Or Sold ONE Drug In ~22 Years.
Raj: You Spent A Lot Of Money To Set Up This Tax Shelter Entity To Do What? Is There A Marketing Corporation In The Cayman Islands That Sells All The Drugs Marketed By Spectrum? Do You Or Any Relations Genetically Or Personally Have Interest In This Marketing Corporation. Do Common Shareholders Share In Any Or All Of The Markups And Or Profits From The Spectrum Cayman Islands Entity Or Entities? What Kind Of Fees Or Commissions Are Being aid To The Facilitators Of The Cayman Island Spectrum Corporation.
You Are One Really Ignorant Paid Pumper! From The SEC. Form D
7. Type of Filing
x New Notice Date of First Sale 2016-04-26
There Is The Proof! Sorry It Is Not In Your Native 3rd World Language.